Xiaodong Teng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Risk Assessment

Top Venues

Clinical endocrinology

Journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Fang Yu, Dongdong Huang, Yeye Kuang, Jian Dong, Qingmei Han, Jie Zhou, Xiaodong Teng
IRS1 promotes thyroid cancer metastasis through EMT and PI3K/AKT pathways. Clinical endocrinology 100 (3) (2024)
Fang Yu, Dongdong Huang, Yeye Kuang, Jian Dong, Qingmei Han, Jie Zhou, Xiaodong Teng
IRS1 promotes thyroid cancer metastasis through EMT and PI3K/AKT pathways. Clinical endocrinology 100 (3) (2024)
Fang Yu, Dongdong Huang, Yeye Kuang, Jian Dong, Qingmei Han, Jie Zhou, Xiaodong Teng
IRS1 promotes thyroid cancer metastasis through EMT and PI3K/AKT pathways. Clinical endocrinology 100 (3) (2024)
Fang Yu, Dongdong Huang, Yeye Kuang, Jian Dong, Qingmei Han, Jie Zhou, Xiaodong Teng
IRS1 promotes thyroid cancer metastasis through EMT and PI3K/AKT pathways. Clinical endocrinology (2024)
Ming Zhao, Jing Song, Xiaona Yin, Jiayun Xu, Xiaodong Teng, Jian Wang
ALK -rearranged mesenchymal neoplasms: a clinicopathological and molecular study of eight additional cases of an emerging group of tyrosine kinase fusion mesenchymal tumours. Journal of clinical pathology (2024)